Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.

Cree BAC, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Lublin FD, Drappa J, Barron G, Madani S, Ratchford JN, She D, Cimbora D, Katz E; N-MOmentum study investigators.

Lancet. 2019 Sep 5. pii: S0140-6736(19)31817-3. doi: 10.1016/S0140-6736(19)31817-3. [Epub ahead of print]

PMID:
31495497
2.

Pathways to Tailor Photocatalytic Performance of TiO2 Thin Films Deposited by Reactive Magnetron Sputtering.

Vahl A, Veziroglu S, Henkel B, Strunskus T, Polonskyi O, Aktas OC, Faupel F.

Materials (Basel). 2019 Sep 3;12(17). pii: E2840. doi: 10.3390/ma12172840. Review.

3.

Controlling fibroblast adhesion and proliferation by 1D Al2O3 nanostructures.

Aktas OC, Metzger W, Mees L, Martinez MM, Haidar A, Oberringer M, Wennemuth G, Pütz N, Ghori MZ, Pohlemann T, Veith M.

IET Nanobiotechnol. 2019 Aug;13(6):621-625. doi: 10.1049/iet-nbt.2018.5088.

PMID:
31432796
4.

Prevalence and characteristics of adult shellfish allergy in the United States.

Warren CM, Aktas ON, Gupta RS, Davis CM.

J Allergy Clin Immunol. 2019 Aug 8. pii: S0091-6749(19)31027-9. doi: 10.1016/j.jaci.2019.07.031. [Epub ahead of print] No abstract available.

PMID:
31401288
5.

Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data.

Sinnecker T, Hadisurya J, Schneider-Hohendorf T, Schwab N, Wrede K, Gembruch O, Gold R, Hellwig K, Pilgram-Pastor S, Adams O, Albrecht P, Hartung HP, Aktas O, Kraemer M.

BMC Neurol. 2019 Aug 9;19(1):190. doi: 10.1186/s12883-019-1407-2.

6.

No Alteration of Optical Coherence Tomography and Multifocal Visual Evoked Potentials in Eyes With Symptomatic Carotid Artery Disease.

Lee JI, Gemerzki L, Boerker L, Guthoff R, Aktas O, Gliem M, Jander S, Hartung HP, Albrecht P.

Front Neurol. 2019 Jul 10;10:741. doi: 10.3389/fneur.2019.00741. eCollection 2019.

7.

Investigation of human papillomavirus prevalence in married women and molecular characterization and phylogenetic analysis of the virus.

Yayla AE, Kadioglu BG, Aydin A, Aktas O.

Obstet Gynecol Sci. 2019 Jul;62(4):264-272. doi: 10.5468/ogs.2019.62.4.264. Epub 2019 Jun 17.

8.

Drug Treatment of Clinically Isolated Syndrome.

Förster M, Graf J, Mares J, Aktas O, Hartung HP, Kremer D.

CNS Drugs. 2019 Jul;33(7):659-676. doi: 10.1007/s40263-019-00647-x. Review.

PMID:
31290079
9.

Factors associated with headache in intravenous immunoglobulin treatment for neurological diseases.

Graf J, Ingwersen J, Lepka K, Albrecht P, Hartung HP, Ringelstein M, Aktas O.

Acta Neurol Scand. 2019 Oct;140(4):290-295. doi: 10.1111/ane.13144. Epub 2019 Jul 23.

PMID:
31269227
10.

Cauliflower-like CeO2-TiO2 hybrid nanostructures with extreme photocatalytic and self-cleaning properties.

Veziroglu S, Röder K, Gronenberg O, Vahl A, Polonskyi O, Strunskus T, Rubahn HG, Kienle L, Adam J, Fiutowski J, Faupel F, Aktas OC.

Nanoscale. 2019 May 28;11(20):9840-9844. doi: 10.1039/c9nr01208g. Epub 2019 Apr 30.

PMID:
31038519
11.

Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change.

Hartung HP, Graf J, Aktas O, Mares J, Barnett MH.

Curr Opin Neurol. 2019 Jun;32(3):327-337. doi: 10.1097/WCO.0000000000000699.

PMID:
30985371
12.

The Prevalence of Mixed Genotype Infections in Turkish Patients with Hepatitis C: a Multicentered Assessment.

Kulah C, Altindis M, Akyar I, Gokahmetoglu S, Sayiner A, Kaleli I, Fidan I, Altuglu I, Aydin F, Topkaya A, Us T, Findik D, Ozdemir M, Oztürk E, Ulger ST, Karsligil T, Cekin Y, Aksaray S, Uzunoglu E, Aktas O, Uslu H, Cetinkol Y, Gureser AS, Ece G, Toptan H, Koroglu M, Comert F.

Clin Lab. 2019 Apr 1;65(4). doi: 10.7754/Clin.Lab.2018.180824.

PMID:
30969089
13.

Regulation of sirtuin expression in autoimmune neuroinflammation: Induction of SIRT1 in oligodendrocyte progenitor cells.

Prozorovski T, Ingwersen J, Lukas D, Göttle P, Koop B, Graf J, Schneider R, Franke K, Schumacher S, Britsch S, Hartung HP, Küry P, Berndt C, Aktas O.

Neurosci Lett. 2019 Jun 21;704:116-125. doi: 10.1016/j.neulet.2019.04.007. Epub 2019 Apr 4.

PMID:
30953735
14.

Food allergy research priorities: Results from a patient-centered study.

Bilaver LA, Sharma HP, Gupta RS, Herbert LJ, Marchisotto MJ, Aktas ON, Jiang J, Miller E.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2431-2433.e4. doi: 10.1016/j.jaip.2019.03.011. Epub 2019 Mar 22. No abstract available.

PMID:
30910713
15.

CSI: Multiple sclerosis. Tracing optic nerve involvement by standardized optical coherence tomography.

Aktas O, Hartung HP.

Ann Neurol. 2019 May;85(5):615-617. doi: 10.1002/ana.25471. Epub 2019 Apr 10. No abstract available.

PMID:
30900764
16.

Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patients.

Kraemer M, Schwitalla JC, Diesner F, Aktas O, Hartung HP, Berlit P.

J Neurol. 2019 Jun;266(6):1421-1428. doi: 10.1007/s00415-019-09277-1. Epub 2019 Mar 13.

PMID:
30868219
17.

How Robust is the N=34 Subshell Closure? First Spectroscopy of ^{52}Ar.

Liu HN, Obertelli A, Doornenbal P, Bertulani CA, Hagen G, Holt JD, Jansen GR, Morris TD, Schwenk A, Stroberg R, Achouri N, Baba H, Browne F, Calvet D, Château F, Chen S, Chiga N, Corsi A, Cortés ML, Delbart A, Gheller JM, Giganon A, Gillibert A, Hilaire C, Isobe T, Kobayashi T, Kubota Y, Lapoux V, Motobayashi T, Murray I, Otsu H, Panin V, Paul N, Rodriguez W, Sakurai H, Sasano M, Steppenbeck D, Stuhl L, Sun YL, Togano Y, Uesaka T, Wimmer K, Yoneda K, Aktas O, Aumann T, Chung LX, Flavigny F, Franchoo S, Gašparić I, Gerst RB, Gibelin J, Hahn KI, Kim D, Koiwai T, Kondo Y, Koseoglou P, Lee J, Lehr C, Linh BD, Lokotko T, MacCormick M, Moschner K, Nakamura T, Park SY, Rossi D, Sahin E, Sohler D, Söderström PA, Takeuchi S, Törnqvist H, Vaquero V, Wagner V, Wang S, Werner V, Xu X, Yamada H, Yan D, Yang Z, Yasuda M, Zanetti L.

Phys Rev Lett. 2019 Feb 22;122(7):072502. doi: 10.1103/PhysRevLett.122.072502.

PMID:
30848641
18.

Enhancing adhesion and alignment of human gingival fibroblasts on dental implants.

Aktas OC, Metzger W, Haidar A, Açil Y, Gülses A, Wiltfang J, Sacramento CM, Nothdurft FP.

J Craniomaxillofac Surg. 2019 Apr;47(4):661-667. doi: 10.1016/j.jcms.2019.02.004. Epub 2019 Feb 21.

PMID:
30846326
19.

Misdiagnoses and delay of diagnoses in Moyamoya angiopathy-a large Caucasian case series.

Graf J, Schwitalla JC, Albrecht P, Veltkamp R, Berlit P, Hartung HP, Aktas O, Kraemer M.

J Neurol. 2019 May;266(5):1153-1159. doi: 10.1007/s00415-019-09245-9. Epub 2019 Feb 25.

PMID:
30805794
20.

The impact of O2/Ar ratio on morphology and functional properties in reactive sputtering of metal oxide thin films.

Vahl A, Dittmann J, Jetter J, Veziroglu S, Shree S, Ababii N, Lupan O, Aktas OC, Strunskus T, Quandt E, Adelung R, Sharma SK, Faupel F.

Nanotechnology. 2019 Jun 7;30(23):235603. doi: 10.1088/1361-6528/ab0837. Epub 2019 Feb 19.

PMID:
30780141
21.

Genetic diversity of primate erythroparvovirus 1 between 2009 and 2016: First report from Turkey.

Aydin H, Timurkan MO, Aktas O.

Microb Pathog. 2019 Apr;129:131-135. doi: 10.1016/j.micpath.2019.02.010. Epub 2019 Feb 10.

PMID:
30742946
22.

Assessing the anterior visual pathway in optic neuritis: recent experimental and clinical aspects.

Dietrich M, Aktas O, Hartung HP, Albrecht P.

Curr Opin Neurol. 2019 Jun;32(3):346-357. doi: 10.1097/WCO.0000000000000675.

PMID:
30694926
23.

Managing Risks with Immune Therapies in Multiple Sclerosis.

Förster M, Küry P, Aktas O, Warnke C, Havla J, Hohlfeld R, Mares J, Hartung HP, Kremer D.

Drug Saf. 2019 May;42(5):633-647. doi: 10.1007/s40264-018-0782-8. Review.

PMID:
30607830
24.

Monoclonal Antibodies for Multiple Sclerosis: An Update.

Graf J, Aktas O, Rejdak K, Hartung HP.

BioDrugs. 2019 Feb;33(1):61-78. doi: 10.1007/s40259-018-0327-9. Review.

PMID:
30604390
25.

Knock-Down of a ligIV Homologue Enables DNA Integration via Homologous Recombination in the Marine Diatom Phaeodactylum tricornutum.

Angstenberger M, Krischer J, Aktaş O, Büchel C.

ACS Synth Biol. 2019 Jan 18;8(1):57-69. doi: 10.1021/acssynbio.8b00234. Epub 2018 Dec 21.

PMID:
30525458
26.

High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy.

Albrecht P, Jansen A, Lee JI, Moll M, Ringelstein M, Rosenthal D, Bigalke H, Aktas O, Hartung HP, Hefter H.

Neurology. 2019 Jan 1;92(1):e48-e54. doi: 10.1212/WNL.0000000000006688. Epub 2018 Nov 21.

PMID:
30464031
27.

Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.

Jensen PEH, Warnke C, Ingenhoven K, Piccoli L, Gasis M, Hermanrud C, Fernandez-Rodriguez BM, Ryner M, Kramer D, Link J, Ramanujam R, Auer M, Buck D, Grummel V, Bertotti E, Fissolo N, Oliver-Martos B, Nytrova P, Khalil M, Guger M, Rathmaier S, Sievers-Stober C, Lindberg RLP, Hässler S, Bachelet D, Aktas O, Donnellan N, Lawton A, Hemmer B, Havrdova EK, Kieseier B, Hartung HP, Comabella M, Montalban X, Derfuss T, Sellebjerg F, Dönnes P, Pallardy M, Spindeldreher S, Broët P, Deisenhammer F, Fogdell-Hahn A, Sorensen PS; ABIRISK Consortium.

J Neuroimmunol. 2019 Jan 15;326:19-27. doi: 10.1016/j.jneuroim.2018.11.002. Epub 2018 Nov 7.

PMID:
30447419
28.

Racial differences in neuromyelitis optica spectrum disorder.

Kim SH, Mealy MA, Levy M, Schmidt F, Ruprecht K, Paul F, Ringelstein M, Aktas O, Hartung HP, Asgari N, Tsz-Ching JL, Siritho S, Prayoonwiwat N, Shin HJ, Hyun JW, Han M, Leite MI, Palace J, Kim HJ.

Neurology. 2018 Nov 27;91(22):e2089-e2099. doi: 10.1212/WNL.0000000000006574. Epub 2018 Oct 26.

PMID:
30366977
29.

Predictors of response to opicinumab in acute optic neuritis.

Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch LJ, Leocani L, Freedman MS, Plant GT, Preiningerova JL, Ziemssen F, Massacesi L, Chai Y, Xu L; RENEW Study Investigators.

Ann Clin Transl Neurol. 2018 Aug 15;5(10):1154-1162. doi: 10.1002/acn3.620. eCollection 2018 Oct.

30.

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Krumbholz M, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl UK, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C; NEMOS (Neuromyelitis Optica Study Group).

Neurol Neuroimmunol Neuroinflamm. 2018 Sep 26;5(6):e504. doi: 10.1212/NXI.0000000000000504. eCollection 2018 Nov.

31.

Vocal fold paralysis due to intracranial hypotension following spinal anesthesia.

Aytuluk HG, Aktas O.

Anaesthesist. 2018 Nov;67(11):868-870. doi: 10.1007/s00101-018-0501-y. Epub 2018 Oct 12.

PMID:
30315318
32.

Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment.

Graf J, Ringelstein M, Lepka K, Schaller J, Quack H, Hartung HP, Aktas O, Albrecht P.

Mult Scler. 2018 Nov;24(13):1776-1778. doi: 10.1177/1352458518771276. Epub 2018 Oct 11.

PMID:
30307371
33.

Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential.

Klistorner A, Chai Y, Leocani L, Albrecht P, Aktas O, Butzkueven H, Ziemssen T, Ziemssen F, Frederiksen J, Xu L, Cadavid D; RENEW MF-VEP Investigators.

CNS Drugs. 2018 Dec;32(12):1159-1171. doi: 10.1007/s40263-018-0575-8.

34.

[MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].

Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B.

Nervenarzt. 2018 Dec;89(12):1388-1399. doi: 10.1007/s00115-018-0607-0. Review. German.

PMID:
30264269
35.

Unilateral Hypoglossal Nerve Palsy After Septoplasty Under General Anaesthesia.

Aytuluk HG, Aktaş Ö.

Turk J Anaesthesiol Reanim. 2018 Jun;46(3):241-244. doi: 10.5152/TJAR.2018.62893. Epub 2017 Jun 1.

36.

Multifocal visual evoked potentials in chronic inflammatory demyelinating polyneuropathy.

Graf J, Jansen L, Ingwersen J, Ringelstein M, Harmel J, Rybak J, Kolbe R, Rhöse L, Gemerzki L, Lee JI, Klistorner A, Guthoff R, Hartung HP, Aktas O, Albrecht P.

Ann Clin Transl Neurol. 2018 Jul 7;5(8):952-961. doi: 10.1002/acn3.593. eCollection 2018 Aug.

37.

Lifetime Measurements of Excited States in ^{172}Pt and the Variation of Quadrupole Transition Strength with Angular Momentum.

Cederwall B, Doncel M, Aktas Ö, Ertoprak A, Liotta R, Qi C, Grahn T, Cullen DM, Hodge D, Giles M, Stolze S, Badran H, Braunroth T, Calverley T, Cox DM, Fang YD, Greenlees PT, Hilton J, Ideguchi E, Julin R, Juutinen S, Raju MK, Li H, Liu H, Matta S, Modamio V, Pakarinen J, Papadakis P, Partanen J, Petrache CM, Rahkila P, Ruotsalainen P, Sandzelius M, Sarén J, Scholey C, Sorri J, Subramaniam P, Taylor MJ, Uusitalo J, Valiente-Dobón JJ.

Phys Rev Lett. 2018 Jul 13;121(2):022502. doi: 10.1103/PhysRevLett.121.022502.

PMID:
30085703
38.

[Diagnosis of multiple sclerosis: revision of the McDonald criteria 2017].

Aktas O, Wattjes MP, Stangel M, Hartung HP.

Nervenarzt. 2018 Dec;89(12):1344-1354. doi: 10.1007/s00115-018-0550-0. Review. German.

PMID:
29876600
39.

An assessment of the relation between bone mineral density and clinic-demographic properties and life quality during postmenopausal period.

Aktaş Ö, Kaplan S, Sezer N.

J Back Musculoskelet Rehabil. 2018;31(5):803-810. doi: 10.3233/BMR-170933.

PMID:
29865030
40.

Pediatric residents' assessment of atopic dermatitis severity for risk assessment of early peanut introduction.

Shea J, Martusiewicz M, Bilaver LA, Aktas ON, Jiang J, Mancini AJ, Gupta RS.

Ann Allergy Asthma Immunol. 2018 Aug;121(2):251-252. doi: 10.1016/j.anai.2018.05.026. Epub 2018 May 31. No abstract available.

PMID:
29859250
41.

Implementation of an Allergic Reaction Reporting Tool for School Health Personnel: A Pilot Study of Three Chicago Schools.

Aktas ON, Kao LM, Hoyt A, Siracusa M, Maloney R, Gupta RS.

J Sch Nurs. 2019 Oct;35(5):316-324. doi: 10.1177/1059840518777303. Epub 2018 May 22. Erratum in: J Sch Nurs. 2018 Nov 30;:1059840518814629.

PMID:
29788794
42.

Endoscopy in otolaryngology utilising smartphone as the capturing device.

Çelikoyar MM, Aktas OT.

J Vis Commun Med. 2018 Jul;41(3):118-121. doi: 10.1080/17453054.2018.1467209. Epub 2018 May 10.

PMID:
29747530
43.

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.

Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B.

J Neuroinflammation. 2018 May 3;15(1):134. doi: 10.1186/s12974-018-1144-2. Review.

44.

Role of natural killer cells in lung cancer.

Aktaş ON, Öztürk AB, Erman B, Erus S, Tanju S, Dilege Ş.

J Cancer Res Clin Oncol. 2018 Jun;144(6):997-1003. doi: 10.1007/s00432-018-2635-3. Epub 2018 Apr 3. Review.

PMID:
29616326
45.

[Cladribine tablets : Oral immunotherapy of relapsing-remitting multiple sclerosis with short yearly treatment periods].

Meuth SG, Ruck T, Aktas O, Hartung HP.

Nervenarzt. 2018 Aug;89(8):895-907. doi: 10.1007/s00115-018-0498-0. Review. German.

PMID:
29523912
46.

Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model.

Dietrich M, Helling N, Hilla A, Heskamp A, Issberner A, Hildebrandt T, Kohne Z, Küry P, Berndt C, Aktas O, Fischer D, Hartung HP, Albrecht P.

J Neuroinflammation. 2018 Mar 7;15(1):71. doi: 10.1186/s12974-018-1111-y.

47.

Nimodipine confers clinical improvement in two models of experimental autoimmune encephalomyelitis.

Ingwersen J, De Santi L, Wingerath B, Graf J, Koop B, Schneider R, Hecker C, Schröter F, Bayer M, Engelke AD, Dietrich M, Albrecht P, Hartung HP, Annunziata P, Aktas O, Prozorovski T.

J Neurochem. 2018 Feb 23. doi: 10.1111/jnc.14324. [Epub ahead of print]

48.

Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge.

Zettl UK, Hecker M, Aktas O, Wagner T, Rommer PS.

Expert Rev Clin Immunol. 2018 Feb;14(2):137-153. doi: 10.1080/1744666X.2018.1426462. Epub 2018 Jan 23.

PMID:
29318902
49.

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy.

Graf J, Leussink VI, Dehmel T, Ringelstein M, Goebels N, Adams O, MacKenzie CR, Warnke C, Feldt T, Lammerskitten A, Klotz L, Meuth S, Wiendl H, Hartung HP, Aktas O, Albrecht P.

Ann Clin Transl Neurol. 2017 Nov 24;4(12):909-914. doi: 10.1002/acn3.491. eCollection 2017 Dec.

50.

Long-term follow-up of tonsillectomy efficacy in children with PFAPA syndrome.

Aktas O, Aytuluk HG, Caliskan SK, Erdur O, Cirik AA.

Braz J Otorhinolaryngol. 2019 Jan - Feb;85(1):78-82. doi: 10.1016/j.bjorl.2017.10.012. Epub 2017 Nov 21.

Supplemental Content

Support Center